Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience

Luigi Gargiulo; Francesco Piscazzi; Luciano Ibba; Mario Valenti; Paola Facheris; Chiara Perugini; Antonio Costanzo; Alessandra Narcisi

doi:10.1080/09546634.2023.2192840

Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience

Luigi Gargiulo, Francesco Piscazzi, Luciano Ibba, Mario Valenti, Paola Facheris, Chiara Perugini, Antonio Costanzo, Alessandra Narcisi

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English
Article number	2192840
Journal	Journal of Dermatological Treatment
Volume	34
Issue number	1
DOIs	https://doi.org/10.1080/09546634.2023.2192840
State	Published - 2023
Externally published	Yes

Access to Document

10.1080/09546634.2023.2192840

Cite this

@article{a8f4663cb92f4527aa2f061bbe20b416,

title = "Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience",

author = "Luigi Gargiulo and Francesco Piscazzi and Luciano Ibba and Mario Valenti and Paola Facheris and Chiara Perugini and Antonio Costanzo and Alessandra Narcisi",

year = "2023",

doi = "10.1080/09546634.2023.2192840",

language = "English",

volume = "34",

journal = "Journal of Dermatological Treatment",

issn = "0954-6634",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

TY - JOUR

T1 - Dupilumab for the treatment of atopic dermatitis of the elderly

T2 - a real-life 52-week experience

AU - Gargiulo, Luigi

AU - Piscazzi, Francesco

AU - Ibba, Luciano

AU - Valenti, Mario

AU - Facheris, Paola

AU - Perugini, Chiara

AU - Costanzo, Antonio

AU - Narcisi, Alessandra

PY - 2023

Y1 - 2023

UR - https://www.scopus.com/pages/publications/85152170931

U2 - 10.1080/09546634.2023.2192840

DO - 10.1080/09546634.2023.2192840

M3 - Letter

C2 - 36927393

AN - SCOPUS:85152170931

SN - 0954-6634

VL - 34

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

IS - 1

M1 - 2192840

ER -